By Josh Beckerman
Teva Pharmaceutical Industries Ltd. (TEVA) shares recently traded up 12% to $8.41 as it said it reached a framework for a multistate settlement of opioid-related litigation.
Teva would donate buprenorphine naloxone tablets with a value of about $23 billion (at wholesale acquisition cost) over 10 years, and make a cash payment of up to $250 million over 10 years.
Teva and other companies also reached a settlement with two Ohio counties.
Write to Josh Beckerman at email@example.com